Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniaeinfection in Fukuoka, Japan
Open Access
- 16 December 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 13 (1), 591
- https://doi.org/10.1186/1471-2334-13-591
Abstract
Recent epidemiologic data suggest that the prevalence of macrolide resistant Mycoplasma pneumoniae (MR-M. pneumoniae) is increasing rapidly worldwide. This study assessed the present status of M. pneumoniae infection in Japan and clinical end-points to distinguish children with MR-M. pneumoniae. During an outbreak of M. pneumoniae infections in Fukuoka, Japan in 2010–11, a total of 105 children with clinically suspected M. pneumoniae infection were enrolled. M. pneumoniae was analyzed for macrolide resistance in domain V of the 23S rRNA gene. Sixty -five patients with PCR positive for M. pneumoniae were analyzed with regard to clinical symptoms, efficacy of several antimicrobial agents and several laboratory data. Causative pathogens were detected in 81.0% (85 of 105) and M. pneumoniae was identified 61.9% (65 of 105). The resistance rate of M. pneumoniae was 89.2% (58 of 65) in this general pediatric outpatient setting. Patients infected with MR-M. pneumoniae showed longer times to resolution of fever and required frequent changes of the initially prescribed macrolide to another antimicrobial agent. We observed three different genotypes of M. pneumoniae including the rarely reported A2063T mutation (A2063G: 31 strains, A2063T: 27 strains, no mutation: 7 strains). Drug susceptibility testing showed different antimicrobial susceptibility profiles for each genotype. Serum IFN-gamma, IL-6 and IP-10 levels were higher in patients with MR-genotypes than in those infected with no-mutation strains (p < 0.001). Macrolide resistance is more common than previously thought and a small epidemic of rarely reported A2063T mutation was observed in Fukuoka, Japan. Furthermore our results reveal the possibility that levels of certain inflammatory cytokines may be a candidate to predict MR-M.pneumoniae infection.Keywords
This publication has 26 references indexed in Scilit:
- Macrolide-ResistantMycoplasma pneumoniaein Humans, Ontario, Canada, 2010–2011Emerging Infectious Diseases, 2013
- Macrolide Resistance ofMycoplasma pneumoniae,South Korea, 2000–2011Emerging Infectious Diseases, 2013
- Rising Rates of Macrolide-Resistant Mycoplasma pneumoniae in the Central United StatesThe Pediatric Infectious Disease Journal, 2012
- Nested PCR-Linked Capillary Electrophoresis and Single-Strand Conformation Polymorphisms for Detection of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, ChinaJournal of Clinical Microbiology, 2010
- High Prevalence of Macrolide Resistance inMycoplasma pneumoniaeIsolates from Adult and Adolescent Patients with Respiratory Tract Infection in ChinaClinical Infectious Diseases, 2010
- Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for Molecular Typing of Mycoplasma pneumoniaeJournal of Clinical Microbiology, 2009
- Detection of Macrolide Resistance inMycoplasma pneumoniaeby Real-Time PCR and High-Resolution Melt AnalysisAntimicrobial Agents and Chemotherapy, 2008
- Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2008
- First Report of Macrolide-Resistant Strains and Description of a Novel Nucleotide Sequence Variation in the P1 Adhesin Gene in Mycoplasma pneumoniae Clinical Strains Isolated in France over 12 YearsJournal of Clinical Microbiology, 2007
- DNA Replication Errors Produced by the Replicative Apparatus of Escherichia coliJournal of Molecular Biology, 1999